Prelude Capital Management’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-9,400
| Closed | -$1.06M | – | 1364 |
|
2025
Q1 | $1.06M | Sell |
9,400
-5,334
| -36% | -$604K | 0.08% | 244 |
|
2024
Q4 | $1.56M | Buy |
+14,734
| New | +$1.56M | 0.1% | 207 |
|
2024
Q2 | – | Sell |
-3,644
| Closed | -$481K | – | 1452 |
|
2024
Q1 | $481K | Buy |
+3,644
| New | +$481K | 0.03% | 583 |
|
2023
Q4 | – | Sell |
-5,156
| Closed | -$579K | – | 1283 |
|
2023
Q3 | $579K | Buy |
+5,156
| New | +$579K | 0.04% | 344 |
|
2023
Q1 | – | Sell |
-5,537
| Closed | -$706K | – | 1388 |
|
2022
Q4 | $706K | Buy |
5,537
+1,508
| +37% | +$192K | 0.04% | 410 |
|
2022
Q3 | $421K | Buy |
4,029
+1,396
| +53% | +$146K | 0.02% | 698 |
|
2022
Q2 | $277K | Sell |
2,633
-4,808
| -65% | -$506K | 0.01% | 945 |
|
2022
Q1 | $952K | Buy |
+7,441
| New | +$952K | 0.03% | 477 |
|
2020
Q3 | – | Sell |
-5,637
| Closed | -$653K | – | 1925 |
|
2020
Q2 | $653K | Buy |
+5,637
| New | +$653K | 0.04% | 228 |
|
2020
Q1 | – | Sell |
-412
| Closed | -$60K | – | 1646 |
|
2019
Q4 | $60K | Sell |
412
-5,576
| -93% | -$812K | ﹤0.01% | 892 |
|
2019
Q3 | $798K | Buy |
+5,988
| New | +$798K | 0.04% | 210 |
|
2016
Q4 | – | Sell |
-2,849
| Closed | -$360K | – | 1752 |
|
2016
Q3 | $360K | Buy |
+2,849
| New | +$360K | 0.04% | 334 |
|
2015
Q4 | – | Sell |
-8,979
| Closed | -$819K | – | 1634 |
|
2015
Q3 | $819K | Sell |
8,979
-466
| -5% | -$42.5K | 0.12% | 179 |
|
2015
Q2 | $1M | Sell |
9,445
-1,164
| -11% | -$123K | 0.14% | 168 |
|
2015
Q1 | $1.21M | Buy |
+10,609
| New | +$1.21M | 0.17% | 155 |
|
2014
Q4 | – | Sell |
-1,673
| Closed | -$163K | – | 2062 |
|
2014
Q3 | $163K | Buy |
1,673
+1,272
| +317% | +$124K | 0.02% | 730 |
|
2014
Q2 | $40K | Sell |
401
-505
| -56% | -$50.4K | 0.01% | 1324 |
|
2014
Q1 | $83K | Buy |
+906
| New | +$83K | 0.01% | 964 |
|